Goraya Harmeen, Meena Nikhil, Jagana Rajani
Pulmonary and Critical Care, University of Arkansas for Medical Sciences, Little Rock, USA.
Cureus. 2022 Aug 9;14(8):e27823. doi: 10.7759/cureus.27823. eCollection 2022 Aug.
Coronavirus disease 2019 (COVID-19) has dramatically shifted the healthcare landscape since 2020. Measures against it includes universal masking in the healthcare areas and the community, viral testing before aerosolizing procedures, and ambulatory elective surgical procedures. Some hospitals have had mandated viral testing policies even before admission to the hospital. Healthcare workers (HCWs) have been cautiously modifying all pertinent practices to avoid the transmission of the virus. Personal protective equipment (PPE), including gowns, gloves, eye protection, and properly fitted N95 respirator or powered air-purifying respirators (PAPR) while treating the suspected and confirmed COVID-19 patients were made mandatory. Similarly, we changed our aerosol-generating procedures (AGPs) protocols based on available limited data. We amended our approach to in-hospital cardiopulmonary resuscitation (basic life support (BLS)/advanced cardiovascular life support (ACLS)), given the risk of aerosol generation and transmission during the process. This article shares our experience and outcomes of PPE use in healthcare emergencies at our tertiary care academic center.
自2020年以来,2019冠状病毒病(COVID-19)极大地改变了医疗格局。针对该疾病的措施包括在医疗区域和社区普遍佩戴口罩、在进行雾化操作前进行病毒检测以及非急诊择期手术。一些医院甚至在患者入院前就实施了强制病毒检测政策。医护人员一直在谨慎调整所有相关操作,以避免病毒传播。在治疗疑似和确诊的COVID-19患者时,个人防护装备(PPE),包括隔离衣、手套、眼部防护用品以及佩戴合适的N95口罩或动力空气净化呼吸器(PAPR)成为强制要求。同样,我们根据有限的现有数据改变了雾化产生操作(AGP)方案。鉴于在院内心肺复苏(基础生命支持(BLS)/高级心血管生命支持(ACLS))过程中产生和传播气溶胶的风险,我们修改了相关方法。本文分享了我们在三级医疗学术中心应对医疗紧急情况时使用个人防护装备的经验和结果。